newsfilter
← Latest News
GlobeNewswire·

Aravive to Host Key Opinion Leader Symposium on May 11, 2022

HOUSTON, May 05, 2022 (GLOBE NEWSWIRE) -- Aravive, Inc. (NASDAQ:ARAV), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced that it will host a Key Opinion Leader (KOL) Symposium on the GA